18286200

Source:http://linkedlifedata.com/resource/pubmed/id/18286200

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006147, umls-concept:C0019682, umls-concept:C0019699, umls-concept:C0040808, umls-concept:C0205195, umls-concept:C1280519, umls-concept:C1521797, umls-concept:C1523987
pubmed:issue	2
pubmed:dateCreated	2008-2-20
pubmed:abstractText	We assessed the 18-month effectiveness of short-course (sc) antiretroviral peripartum regimens combined with alternatives to prolonged breastfeeding to prevent mother-to-child transmission (MTCT) of HIV-1 in Abidjan, Côte d'Ivoire.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-10459958, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-10459959, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-10703779, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-11371706, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-11579248, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-11746335, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-11873008, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-11955535, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-12441805, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-12824787, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-12965885, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-13678973, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15090779, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15181561, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15247338, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15365003, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15718842, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-15956387, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16088820, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16088821, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16227795, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16284538, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16409681, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16425126, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-16905785, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-17031317, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-17713983, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-8965861, http://linkedlifedata.com/resource/pubmed/commentcorrection/18286200-9605804
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101285081
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-HIV Agents, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Nevirapine, http://linkedlifedata.com/resource/pubmed/chemical/Zidovudine
pubmed:status	MEDLINE
pubmed:issn	1932-6203
pubmed:author	pubmed-author:ANRS 1201/1202 DITRAME PLUS Study Group, pubmed-author:BecquetRenaudR, pubmed-author:DabisFrançoisF, pubmed-author:Dequae-MerchadouLaurenceL, pubmed-author:HoroAppolinaireA, pubmed-author:HurstC ECE, pubmed-author:LeroyValérianeV, pubmed-author:RouetFrançoisF, pubmed-author:RouziouxChristineC, pubmed-author:SakarovitchCharlotteC, pubmed-author:Timité-KonanMargueriteM, pubmed-author:Tonwe-GoldBesiginB, pubmed-author:VihoIdaI
pubmed:issnType	Electronic
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	e1645
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:18286200-Africa, pubmed-meshheading:18286200-Anti-HIV Agents, pubmed-meshheading:18286200-Breast Feeding, pubmed-meshheading:18286200-Drug Therapy, Combination, pubmed-meshheading:18286200-Female, pubmed-meshheading:18286200-HIV Infections, pubmed-meshheading:18286200-Humans, pubmed-meshheading:18286200-Infant, pubmed-meshheading:18286200-Infant, Newborn, pubmed-meshheading:18286200-Infectious Disease Transmission, Vertical, pubmed-meshheading:18286200-Lamivudine, pubmed-meshheading:18286200-Nevirapine, pubmed-meshheading:18286200-Proportional Hazards Models, pubmed-meshheading:18286200-Survival Rate, pubmed-meshheading:18286200-Treatment Outcome, pubmed-meshheading:18286200-Zidovudine
pubmed:year	2008
pubmed:articleTitle	18-month effectiveness of short-course antiretroviral regimens combined with alternatives to breastfeeding to prevent HIV mother-to-child transmission.
pubmed:affiliation	French National Institute for Health and Medical Research (INSERM), Unité 897, Centre de recherche "Epidémiologie et Biostatistique", Bordeaux, France. valeriane.leroy@isped.u-bordeaux2.fr
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't